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Supramolecular chemistry opened up opportunities and 
prospects in biological studies. Numerous supramolecu-
lar systems are known which assume different shapes 
depending on the structure of the component mole-
cules. Some of them are mixed systems. Ribbon-like su-
pramolecular structures which are the main focus of this 
paper form complexes with proteins in a way which is a 
new type of interaction. Despite preserving the ribbon-
like structure, it may also interact with proteins as a 
mixed system. In this way, it may be used as a carrier of 
drugs. In addition, hybrid systems created by a combina-
tion of ribbon-like supramolecular structures with car-
bon nanotubes were presented together with data from 
studies of these structures as drug-carrying systems. This 
paper presents an outline of the experimentally con-
firmed possible use of ribbon-like supramolecular sys-
tems.
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INTRODUCTION
Supramolecular chemistry describes the phenomena 
of self-association of individual molecules to form large 
aggregates. Their formation is based on non-covalent 
bonds and hydrophobic interactions in particular. Su-
pramolecular systems formed as a result of these inter-
actions are composed of a large number of molecules 
and include mono- and polymoieties, micelles, vesicles, 
liposomes, liquid crystals and also inclusive complexes of 
host-guest type and small aggregates containing several 
molecules only as well (Atwood 2004, Xin et al., 2019). 
Supramolecular chemistry is used in many disciplines of 
biology and medicine. It represents structures which may 
be used as adsorbents of gases and many other poorly 
soluble substances. In such cases, they may play a role 
of carriers for drugs or active substances such as cos-
metics for example (Kang et al., 2002; Chen et al., 2016; 
Webber et al., 2016; Yu et al., 2017; Xin et al., 2019). 
Of special interest appeared supramolecular structures 
of ribbon-like configuration. They are formed by sym-
metric, planar, polyaromatic ring molecules as Congo 
red for example. The supramolecular structures of this 
kind penetrate and anchor within the protein body if it 
is unstable and hence susceptible to the penetration of 
large ligands (Roterman & Konieczny, 2018). Instability 
which is correlated with the function of protein is tightly 
connected to the dye complexation with protein activity. 
Antibodies in the immune complex are an example of 
such proteins. They may be used in the immune-target-
ing system directed, among others, to tumors. The selec-
tivity of the carriers can be achieved by using antibodies 
which bind to receptors overexpressed on tumor cells 
(Piekarska et al., 2004).
SUPRAMOLECULAR SYSTEMS
Interaction with proteins and nucleic acids is a hall-
mark of supramolecular systems. Calixarenes have been 
employed for protection, activation or inhibition of en-
zymes. These systems are also useful as anticoagulants, 
for specific binding to lectins and detection of the path-
ogenic prion protein. Formation of the double helix of 
DNA from complementary single polynucleotide strands 
is one of the better-known self-association processes in 
nature.
The complexes with metals which are sensitive to al-
losteric control lead to formation of new bioactive DNA 
ligands. These ligands allow for selective splitting the se-
quences. Cancer treatment with platinum derivatives is 
one of the more interesting applications of metal-bearing 
complexes. Those studies revealed how the addition of 
functional groups in such complexes could significantly 
increase their efficacy and be promising from a biolog-
ical targeting perspective. New derivatives of platinum 
can help solve problems with its toxicity. Selectivity can 
be achieved by using ligands which bind to receptors 
hyperexpressed in tumors (Wells et al., 2007; Schneider, 
2013).
Supramolecular structures are multi-molecular asso-
ciates formed through non-covalent interactions, which 
contributes to their elasticity. The shape of the final 
Figure 1. Examples of supramolecular systems consisting of in-
dividual molecules that form different angles during association 
resulting in bent, circular or spherical structures
Vol. 66, No 4/2019
545–549
https://doi.org/10.18388/abp.2019_2910
546           2019A. Jagusiak
supramolecular structures depends on their component 
molecules. Single molecules that associate under various 
angles form bent, circular or spherical final structures. 
Unidirectionally aligned molecules create membranous or 
cross-linked forms (Fig. 1).
On the other hand, flat, elongated, symmetrical mol-
ecules form ribbon-like structures. The different rib-
bon-like systems have been described in many publica-
tions, but new applications and possible discoveries in 
this field are still in progress (Roterman et al., 2018). 
Below we present an overview of their possible applica-
tions in interaction with proteins, as potential drug car-
riers, with carbon nanotubes, and in imaging techniques.
RIBBON-LIKE SUPRAMOLECULAR SYSTEMS: 
INTERACTION WITH PROTEINS
Proteins usually perform their function by the for-
mation of complexes with other proteins or reactions 
with low-molecular-weight organic or inorganic ligands. 
Complexation of ligands in biology is usually limited to 
a certain area termed the active site but the actual bind-
ing site is formed in contact with the ligand to match its 
structure. By folding, polypeptide chain forms a coher-
ent structure stabilized at the so-called global minimum. 
Thus, the protein is a coherent structure. A local change 
in the structure within the active site induces alterations 
in the molecule outside of the active site. These structur-
al changes are a sign of destabilization because after the 
ligand release the structure returns to the initial form. 
The presence of unstable areas in the protein facilitates 
the penetration of different chemical compounds while 
non-specific interactions of these compounds are weak 
and structure destabilization induced by ligand binding 
cannot be preserved after its release. An appropriate 
ligand which would be capable of preventing the pro-
tein return to its initial form should be large in order to 
ensure multi-point contact and concomitantly elastic to 
allow for structural changes of the ligand to match the 
surroundings. Ligands able to meet these requirements 
were found among supramolecular structures. Congo red 
(CR) is a typical representative of supramolecular com-
pounds of this group (Fig. 2) (Laskowski et al., 2009; 
McLaughlin et al., 2012).
The ribbon-like structures or ribbon fragments of 
Congo red type create conditions that facilitate their 
penetration and binding in unstable areas of protein 
molecules far away from the active site. Spatial changes 
of the active site induced by the attachment of natural 
ligand and by supramolecular ligand binding are coupled. 
If the change in protein structure enables supramolecular 
ligand penetration and its stable binding is dependent on 
the protein function, namely natural ligand binding, then 
reversibility of the process is suppressed. At the same 
time, it means that the link between the protein and 
naturally non-dissociable ligand is strengthened (Fig. 3). 
This inhibition of reversibility in the case of enzymatic 
processes is called uncompetitive inhibition (Fig. 4).
However, in the case of proteins which naturally 
form complexes (e.g. antibodies) we observe a consid-
erable amplification of the binding. It can be observed 
by recording the agglutinating activity of polyclonal 
anti-SRBC (anti-Sheep Red Blood Cells) antibodies at in-
creasing concentrations of Congo red. Due to the vari-
ability of the immune response, the produced pool of 
antibodies has polyclonal character, i.e. anti-SRBC anti-
bodies show a differential affinity for the antigen. Only 
a small fraction presents the affinity sufficiently high to 
induce red blood cell agglutination. The remaining anti-
bodies of the pool, which can be defined as weak, show 
affinities gradually decreasing to zero. In the presence of 
Congo red, engagement of antibodies in red blood cell 
agglutination rises. This engagement progresses with in-
creasing CR concentration. This unusual phenomenon is 
explained – as mentioned earlier – by the elevated irre-
versibility of the process of Ag-Ab complex formation. 
Weak antibodies remain in the complex briefly or very 
briefly but even a short contact with the antigen induc-
es structural changes which enable CR complexation. 
It is the easier the higher CR concentration is because 
CR complexation is possible only in the supramolecular 
form, i.e. with the associated molecules while the associ-
ation increases with the concentration. It is crucial that 
Figure 2. Congo red – a typical representative of supramolecu-
lar ribbon-like systems: 
(A) an individual molecule of CR; (B) supramolecular ribbon-like 
structure created by individual Congo red molecules; (C) interac-
tion of CR with polypeptide chains
Figure 3. Local structure change in the area of the active group 
of the protein after ligand binding causes destabilization of the 
protein molecule outside the active group and, as a result, cre-
ates the possibility of binding e.g. supramolecular systems of 
the Congo red type
Figure 4. Michaelis-Menten equation for uncompetitive inhibi-
tion
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the ability of the antibody to form a complex with CR is 
generated by the reaction of the antibody with the anti-
gen. Free antibodies do not react with Congo red. This 
mechanism corresponds to uncompetitive inhibition in 
the case of enzymes since it perpetuates the enzyme-sub-
strate complex existence by preventing its disintegration. 
In this way, it inhibits the reaction which by nature 
should be reversible (Piekarska et al., 2004; Roterman et 
al., 2018). This uniqueness of action is particularly con-
spicuous in the case of complement. Congo red signifi-
cantly strengthens c1q complexation with antibodies but 
it concomitantly inhibits convertase, thus the overall ef-
fect will be the suppression of the complement action 
(Fig. 5) (Jagusiak et al., 2015).
Unstable proteins also react with Congo red. IgG light 
chains, which often pose a risk to the organism, belong 
to such instable proteins. For instance, these chains typ-
ically occur in the serum of myeloma patients. If the 
instability of these pathological serum components is 
significant, they can aggregate in the kidneys causing 
their blockade and urinary tract failure. The intensity of 
complexation of Congo red and its derivatives can be 
an early indicator of the degree of instability and thus 
of the risk, which can be helpful in taking the necessary 
preventive measures (Fig. 6) (Piekarska et al., 2001, Król 
et al., 2005).
These studies were carried out by Spólnik and others 
(Spólnik et al., 2003) and led to the development of the 
instability assessment methods. However, in the most in-
teresting cases, protein, as a result of its function, makes 
available the supramolecular ligand binding sites in its 
structure. Such a situation can be used in clinical and 
diagnostic practice. Apart from antibodies, acute phase 
proteins can be mentioned here as examples (Wang et al., 
2016). Acute phase proteins belong to the serum com-
ponents. They are capable of the uptake and removal of 
harmful products of metabolic processes from the se-
rum. This activity significantly rises in pathological cases, 
including cancer. They most often bind the proteolytic 
enzymes which due to specific function can penetrate 
to blood. They also remove cell breakdown products, 
which accompany especially inflammation or cancer. 
Free hemoglobin released as a result of red blood cell 
destruction may also be dangerous.
By forming complexes with substances drawn from 
blood, acute phase proteins become susceptible to Con-
go red binding. CR binding alters the protein charge 
making it more negative. Thus, the proteins can be sepa-
rated by serum electrophoresis and provide valuable in-
formation on pathological processes progressing in the 
body. For that purpose, two-dimensional electrophoresis 
of serum proteins is carried out. During the electropho-
resis in the second dimension, perpendicular to the first 
one, Congo red is loaded below the proteins separated 
in the first run. Congo red migrates fast and outruns 
Figure 5. Effect of enhancing c1q complexation with anti-SRBC 
(sheep red blood cells) antibodies when binding to SRBC with 
(or without) Congo red
(A) % of hemolysis without CR; (B) % of hemolysis with CR com-
plexed with anti-SRBC antibodies bound to erythrocytes (Congo 
red is only bound to the antibodies that are stretched by binding 
with both arms); (C) % of hemolysis with CR complexed with c1q 
bound to anti-SRBC antibodies interacting with erythrocytes; (D) 
% of hemolysis with CR complexed with c1q bound to anti-SRBC 
antibodies complexed with CR and associated with erythrocytes 
(Congo red is only bound to the antibodies that are stretched by 
binding with both arms)
Figure 6. The light chain (Lλ) complexed with Congo red mi-
grates faster than the free protein during electrophoretic sepa-
ration on an agarose gel: 
(A) CR visible after electrophoretic separation; (B) samples A after 
visualization of the light chain (CR visible in the background); 1, 
Congo red; 2, Lλ - chain; 3, Lλ-chain and Congo red complex
Figure 7. Interaction of unstable serum proteins with Congo 
red: bi-directional electrophoresis images: 
(A) stage I, electrophoretic separation of serum proteins (migra-
tion to the left: direction indicated by the arrow); (B) stage II, 
electrophoresis in the second direction (from bottom to the top: 
direction indicated by the arrow) of serum proteins separated in 
stage I, but with the addition of Congo red (red line below). Nor-
mal, non-CR-binding proteins are visible on the black dotted line. 
Proteins above the dotted line (marked with a green circle) are af-
fected proteins that travel faster after binding to CR. Insert: photo 
of an electrophoretic separation of the serum proteins of a patient 
with multiple myeloma
Figure 8. Model of complexing Congo red with antibodies 
bound by receptors present on the surface of monocytes and 
their interaction with cancer cells. Congo red is only bound to 
the antibodies that are stretched by binding with both arms.
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the migrating proteins forming complexes with those of 
them whose structure allows for the dye penetration.
Proteins attached to Congo red migrate faster and 
after electrophoresis, their bands are located above the 
CR-unbound proteins. The red color of Congo red is 
removed by reduction while proteins are fixed and vis-
ualized by classical bromophenol blue staining (Fig. 7) 
(Spólnik et al., 2004).
Congo red also forms complexes with albumin, apoli-
poproteins, alfa-1-proteinase (Roterman & Konieczny, 
1998, Stopa et al., 2006) and with receptors of interacting 
cells, e.g. monocytes and cancer cells (Fig. 8) (Roterman 
et al., 2018).
RIBBON-LIKE SUPRAMOLECULAR SYSTEMS: HOST-
GUEST INTERACTIONS
Supramolecular structures reveal also other atypical 
properties which can find practical applications. These 
possibilities arise due to the non-covalent attachment of 
molecules in the supramolecular systems. Because of that, 
the foreign molecules can intercalate into the system as 
guest compounds, which endows the supramolecular sys-
tem some new characteristics. Rhodamine B, a strongly 
fluorescent dye, dissolved in Congo red can be an exam-
ple of such a system. Binding of such mixed system is 
suitable for observation of immune complex formation 
with the use of UV spectrometry since Rhodamine B dis-
tinctly highlights Congo red indicating that the mixed sys-
tem binding to antibodies (Fig. 9) (Konieczny et al., 1997; 
Rybarska et al., 2004; Roterman et al., 2018).
Also, drugs can intercalate into the ribbon-like supra-
molecular system which can reach immune complexes 
capable of specific binding the supramolecular ligands. 
In this way, targeted drug delivery can be achieved, in 
this case termed immunotargeting. Such experiments 
were carried out using the model drug doxorubicin. The 
molecular modeling of doxorubicin interaction with dif-
ferent supramolecular systems (Congo red, Evans blue 
and Titan yellow) demonstrated that such mixed supra-
molecular systems indeed could be formed (Roterman et 
al., 2018; Jagusiak & Pańczyk, 2019).
This approach can also be used for contrast applica-
tion in electron microscopy. Experiments of this type 
were performed by binding silver ions (Ag+) with Titan 
yellow (TY) which besides binding the metal ions forms 
complexes with proteins, just like Congo red. Alterna-
tively, both dyes (TY and CR) may be combined. In this 
way, the development of amyloid fibril structures could 
be followed. Figure 10 presents the developing amyloid 
fibrils stained with the above-mentioned positive dye 
(Rybarska 2017).
Apart from the use of the above-described TY-Ag 
system in analytical techniques, its application in micro-
biology was tested as an alternative to antibiotic therapy. 
The administration of such supramolecular system has 
a great advantage of reducing silver toxicity. The mixed 
system Congo red-Titan yellow-Ag is also more soluble 
and is able to remove the excess of compounds from 
the body (Roterman et al., 2018).
RIBBON-LIKE SUPRAMOLECULAR SYSTEMS: 
INTERACTION WITH CARBON NANOTUBES
Carbon nanotubes provide another possibility of using 
supramolecular dyes as they bind large amounts of Con-
go red until their dissolution in aqueous solution due to 
acquiring a strong negative charge. It creates an oppor-
tunity to achieve a greater concentration of the dye and 
thus a locally higher concentration of the drug (Fig. 11). 
It was shown that CR interacted with carbon nanotube 
surface via „face to face” stacking. Despite the interac-
tion with carbon nanotubes, CR preserves the binding 
capability of other molecules, e.g. model drugs (doxoru-
bicin). Triple systems comprising nanotube-CR-doxoru-
bicin were analyzed along with drug release and its ac-
tion on cells in culture. The results revealed promising 
new hybrid systems created by coupling the ribbon-like 
supramolecular structures intercalating drugs with car-
bon nanotubes. These systems are characterized by a 
high drug binding capacity and the capability of gradual 
drug release at lowered pH. Such compounds represent 
a promising solution in many fields of biomedicine of-
Figure 9. Model of SRBC agglutination with anti-SRBC antibod-
ies – the effect of enhancing agglutination due to the use of CR. 
By complexing CR with Rhodamine B, the potential for immuno-
targeting of model compounds is increased.
Figure 10. Amyloid fibrils beta 1-40 associated with the CR-TY-
Ag triple complex
Figure 11. Carbon nanotubes provide possibility of binding 
Congo red supramolecular structure and mixed structures: Con-
go red intercalated by foreign molecules as guest compounds.
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fering a wide range of potential applications (Jagusiak et 
al., 2017, Jagusiak & Pańczyk, 2019).
CONCLUSIONS
A broad array of applications of supramolecular sys-
tems results from a wide spectrum of potential advan-
tages they provide. Different shapes of association prod-
ucts and the ability to form mixed structures and thus 
to modify the properties appear particularly attractive. 
Biological actions are principally the effect of the inter-
action of certain types of supramolecular structures with 
proteins by penetration of protein molecule in the area 
showing reduced stability. It is especially pertinent to rib-
bon-like systems. Instability caused by ligand binding is 
also encountered in the normal functioning of proteins. 
In such a situation, penetration of supramolecular ligand 
stabilizes the protein in the active state. If it affects a 
reversible process, like in the case of enzymes, the effect 
is manifested as inhibition. Conversely, if it influences a 
process which is sustainable by nature, then it results in 
its enhancement. Understandably, supramolecular ligand 
binding to proteins is attractive especially if mixed struc-
tures are created because a drug can become the guest 
compound intercalating the supramolecular system. Since 
the ribbon-like supramolecular structures eagerly bind to 
the immune complexes, it creates an opportunity for the 
development of immunotargeting techniques.
Supramolecular ligands can also be used in diagnos-
tic procedures because they are able to change physico-
chemical properties of proteins upon the formation of 
mixed structures, enabling the system to interact with 
selected objects.
Congo red, commonly accepted as a standard system, 
is virtually non-toxic since it does not cross plasma mem-
branes of normal cells and is quickly excreted from the 
organism. However, it can be toxic when ingested because 
CR is reduced by intestinal bacteria to form benzidine 
which is thought to be carcinogenic. However, this danger 
can be reduced by the consumption of high-cellulose prod-
ucts during CR administration since cellulose strongly binds 
CR and radically diminishes its susceptibility to reduction.
In comparison to the known supramolecular systems 
presented to date, the ribbon-like structures seem to be 
particularly interesting because they can be applied both 
in diagnostics and development of precise drug delivery 
systems and as an alternative to increasingly ineffective 
antibiotic therapy. Based on the studies conducted so 
far, it can be expected that investigations of these inter-
esting systems will bring new efficient solutions both in 
therapy and diagnostics in the future.
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